Viewing data from:

PRIMIDONE

ANDA

PRIMIDONE | A214896 | RUBICON RESEARCH LTD

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MYSOLINE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 8 NDCs

Highest NADAC/Unit

$1.37

per ea

Lowest NADAC/Unit

$0.0925

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
52817011710PRIMIDONE 125 MG TABLET	$1.37	EA	Generic	—	2026-06-17
72603061001PRIMIDONE 250 MG TABLET	$0.2262	EA	Generic	—	2026-06-17
72888004601PRIMIDONE 250 MG TABLET	$0.2262	EA	Generic	—	2026-06-17
72888004605PRIMIDONE 250 MG TABLET	$0.2262	EA	Generic	—	2026-06-17
72888004505PRIMIDONE 50 MG TABLET	$0.0925	EA	Generic	—	2026-06-17
72603060902PRIMIDONE 50 MG TABLET	$0.0925	EA	Generic	—	2026-06-17
72888004501PRIMIDONE 50 MG TABLET	$0.0925	EA	Generic	—	2026-06-17
72603060901PRIMIDONE 50 MG TABLET	$0.0925	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs2 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

SIEGFRIED LTDPRIMIDONE

DMF 21991973

DR REDDYS LABORATORIES LTDPRIMIDONE

DMF 200072006

NANTONG JINGHUA PHARMACEUTICAL CO LTDPRIMIDONE

DMF 216022008

BIOPHORE INDIA PHARMACEUTICALS PVT LTDPRIMIDONE

DMF 352022020

RAKS PHARMA PVT LTDPRIMIDONE USP

DMF 407702024

NANTONG GENERAL PHARMACEUTICAL FACTORYInactivePRIMIDONE USP XXII

DMF 84061990

PROVENTUS LIFE SCIENCES PVT LTDInactivePRIMIDONE

DMF 234442010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 50MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 28, 2022

No patent or exclusivity listings for this strength.

#002 — 250MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 28, 2022

#003 — 125MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 28, 2022